Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michael A. Nukkala"'
Autor:
Kenneth J. Barr, Laura Gehrke, Hing L. Sham, Michael A. Nukkala, Jang Lee, Shi Chung Ng, Nicolette A. Zielinski, Stephen L. Gwaltney, Michael C. Fitzgerald, Stephen K. Tahir, R. Bruce Credo, Akiyo Claiborne, Robert B. Warner, Keith W. Woods, Gang Liu, Ki H. Kim, David Frost, Yu Hua Hui, Kennan C. Marsh, Qun Li, Saul H. Rosenberg, Peter Kovar
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 12:465-469
A series of indole containing oxazolines has been discovered as a result of structural modifications of the lead compound A-105972. The compounds exert their anticancer activity through inhibition of tubulin polymerization by binding at the colchicin
Autor:
Akiyo Claiborne, Gang Liu, David Frost, Ken Jarvis, Jeffery D. Alder, Thomas W. von Geldern, and Qun Li, Joy Bauch, Laura Gehrke, William J. Chiou, Gunawardana Indrani W, Saul H. Rosenberg, Andrew Tasker, Jae Hwan-Soo, Bruce G. Szczepankiewicz, R. Bruce Credo, Yu Hua Hui, Michael A. Nukkala, Nicolette A. Zielinski, J. Ruth Wu-Wong, Stephen L. Gwaltney, Karl W. Mollison
Publikováno v:
Journal of Medicinal Chemistry. 44:4416-4430
During a screen for compounds that could inhibit cell proliferation, a series of new tubulin-binding compounds was identified with the discovery of oxadiazoline 1 (A-105972). This compound showed good cytotoxic activity against non-multi-drug-resista
Autor:
Kenneth J. Barr, Hovis M. Imade, Robert B. Warner, David Frost, Stephen L. Gwaltney, Jang Yun Lee, Hing L. Vernon Hills Sham, R. Bruce Credo, Peter Kovar, Jieyi Wang, Laura Gehrke, Qun Li, Nicolette A. Zielinski, Shi Chung Ng, Michael A. Nukkala
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 11:871-874
Sulfonate analogues of combretastatin A-4 have been prepared. These compounds compete with colchicine and combretastatin A-4 for the colchicine binding site on tubulin and are potent inhibitors of tubulin polymerization and cell proliferation. Import
Autor:
Stephen K, Tahir, Michael A, Nukkala, Nicolette A, Zielinski Mozny, R Bruce, Credo, Robert B, Warner, Qun, Li, Keith W, Woods, Akiyo, Claiborne, Stephen L, Gwaltney, David J, Frost, Hing L, Sham, Saul H, Rosenberg, Shi-Chung, Ng
Publikováno v:
Molecular cancer therapeutics. 2(3)
In this report, we describe the antitumor activity of A-289099, an indolyloxazoline derivative with antimitotic activity. A-289099 decreased the proliferation of a variety of cells with EC(50) values ranging from 5.1 to 12.8 nM in a P-glycoprotein-in